Literature DB >> 6161233

Regulation of adenosine-sensitive adenylate cyclase from rat brain striatum.

M B Anand-Srivastava, R A Johnson.   

Abstract

An adenosine-sensitive adenylate cyclase has been characterized from rat brain striatum. In whole homogenates as well as in particulate fractions, N6-phenylisopropyl adenosine (PIA), 2-chloroadenosine, and adenosine N'-oxide were equipotent in stimulating adenylate cyclase. Although GTP inhibited basal as well as PIA-stimulated activity of whole homogenates, the enzyme showed an absolute dependency on GTP for stimulation by PIA, dopamine, epinephrine, and norepinephrine in a particulate fraction derived from discontinuous sucrose gradient centrifugation. Adenosine exerts two effects on this adenylate cyclase, stimulation at low concentrations and inhibition at high concentrations, suggesting the presence of two adenosine binding sites. The stimulation of adenylate cyclase by PIA was dependent on the concentration of Mg2+. The degree of stimulation by PIA was greater at a low concentration of MG2+, which suggests that stimulation by PIA was accompanied by increasing the apparent affinity for Mg2+. Activation of adenylate cyclase by PIA was blocked by theophylline or 3-isobutyl-1-methylxanthine (IBMX). The pH optimum for basal or (PIA + GTP)-stimulated activities was broad, with a peak between 8.5 and 9.5. In the presence of GTP, stimulation by an optimal concentration of PIA was additive, with maximal stimulation by the catecholamines. Phospholipase A2 treatment at a concentration of 1 U/ml for 5 min completely abolished the stimulatory effect of dopamine, whereas PIA-stimulated activity remained unaltered. These data suggest that rat brain striatum either has a single adenylate cyclase, which is stimulted by catecholamines and adenosine by distinct mechanisms, or has different cyclase populations, stimulated by either adenosine or catecholamines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161233     DOI: 10.1111/j.1471-4159.1980.tb07089.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Adenosine regulates the release of adrenocorticotropic hormone (ACTH) from cultured anterior pituitary cells.

Authors:  M B Anand-Srivastava; M Cantin; J Gutkowska
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

2.  Involvement of phospholipids in the coupling of adenosine and dopamine receptors to rat striatal adenylate cyclase.

Authors:  M B Anand-Srivastava; R A Johnson
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

3.  Activity of adenylate cyclase and 5'-nucleotidase in the sensorimotor and limbic structures of the brain in rats after manipulatory training.

Authors:  I A Zhuravin; N N Nalivaeva; S A Plesneva; N M Dubrovskaya; U B Chekulaeva; B I Klement'ev
Journal:  Neurosci Behav Physiol       Date:  1996 Nov-Dec

4.  The role of calcium in the cyclic AMP response to histamine in rabbit cerebral cortical slices.

Authors:  M Al-Gadi; S J Hill
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

5.  [3H]5'-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum.

Authors:  S M Yeung; R D Green
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

6.  Characterization of adenosine receptor-mediated generation of cyclic AMP in slices of rat cerebral cortex with chronic epileptic activity.

Authors:  Y Hattori; A Moriwaki; Y Hayashi; N Islam; Y Hori
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

7.  Modulation of adenylate cyclase activity by Ca2+, phospholipid-dependent protein kinase in rat brain striatum.

Authors:  M B Anand-Srivastava; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

8.  CNS distribution, signalling properties and central effects of G-protein coupled receptor 4.

Authors:  P S Hosford; V Mosienko; K Kishi; G Jurisic; K Seuwen; B Kinzel; M G Ludwig; J A Wells; I N Christie; L Koolen; A P Abdala; B H Liu; A V Gourine; A G Teschemacher; S Kasparov
Journal:  Neuropharmacology       Date:  2018-06-09       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.